Literature DB >> 7341553

Effects of different doses of apomorphine on GAD activity in rat substantia nigra.

D F Condorelli, G Giammona, F Patti, F Nicoletti, L Rampello, A Reggio, M Matera, R M Di Giorgio.   

Abstract

The effects of different doses of the dopamine (DA) receptor agonist apomorphine on the activity of the gamma-aminobutyric acid (GABA)-synthesizing enzyme glutamic acid decarboxylase (GAD, EC 4.1.1.15) were investigated in rat substantia nigra in comparison with haloperidol and sulpiride, two DA receptor blocking agents. Results obtained show that low doses (10,35 microgram/kg, s.c.) of apomorphine induce a decrease in nigral GAD activity whilst an opposite effect is observed with the highest dose (1000 microgram/kg, s.c.). No significant change is observed following injection of the intermediate doses (100 and 500 microgram/kg, s.c.). Moreover, sulpiride at the dose used (2 mg/kg, i.p.) induces an increase in GAD activity whilst no effect follows systemic injection of the same dose of haloperidol. The results are discussed in light of recent neurochemical and behavioral data.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7341553     DOI: 10.1007/bf02335412

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  16 in total

1.  Interaction of dopaminergic and cholinergic neurons in the extrapyramidal and limbic systems.

Authors:  G Bartholini; H Stadler; M Gadea-Ciria; K G Lloyd
Journal:  Adv Biochem Psychopharmacol       Date:  1977

2.  Brain GABA, dopamine and acetylcholine interactions. 1. Studies with oxotremorine.

Authors:  M Pérez de la Mora; K Fuxe
Journal:  Brain Res       Date:  1977-10-21       Impact factor: 3.252

Review 3.  Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.

Authors:  P F Spano; S Govoni; M Trabucchi
Journal:  Adv Biochem Psychopharmacol       Date:  1978

Review 4.  Interactions between enkephalinergic and other neuronal systems.

Authors:  E Costa; W Fratta; J S Hong; F Moroni; H Y Yang
Journal:  Adv Biochem Psychopharmacol       Date:  1978

5.  On the source of GABA-containing terminals in the substantia nigra. Electron microscopic autoradiographic and biochemical studies.

Authors:  T Hattori; P L McGeer; H C Fibiger; E G McGeer
Journal:  Brain Res       Date:  1973-05-17       Impact factor: 3.252

6.  Origin and distribution of glutamate decarboxylase in substantia nigra of the cat.

Authors:  F Fonnum; I Grofová; E Rinvik; J Storm-Mathisen; F Walberg
Journal:  Brain Res       Date:  1974-05-10       Impact factor: 3.252

7.  The striatal dopaminergic function is mediated by the inhibition of a nigral, non-dopaminergic neuronal system via a strio-nigral GABAergic pathway.

Authors:  M C Olianas; G M De Montis; G Mulas; A Tagliamonte
Journal:  Eur J Pharmacol       Date:  1978-06-01       Impact factor: 4.432

8.  A microprocedure for the measurement of 14CO2 release from [14C]carboxyl-labeled amino acids.

Authors:  M A Beaven; G Wilcox; G K Terpstra
Journal:  Anal Biochem       Date:  1978-02       Impact factor: 3.365

9.  Effects of ethanolamine-O-sulphate and gamma-acetylenic-GABA on GABA content, GAD and GABA-T in various areas of chick brain after intraventricular microinjection.

Authors:  G Nisticó; R M Di Giorgio; G De Luca; S Macaione
Journal:  J Neurochem       Date:  1979-07       Impact factor: 5.372

10.  Effect of apomorphine on the GABA turnover in the DA cell group rich area of the mesencephalon. Evidence for the involvement of an inhibitory gabergic feedback control of the ascending DA neurons.

Authors:  M Pérez de la Mora; K Fuxe; T Hökfelt; A Ljungdahl
Journal:  Neurosci Lett       Date:  1975-08       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.